The Business Times
business-time-50
INVESTING GLOBALLY & PROFITABLY

Global healthcare: From laggards to opportunities

The healthcare sector sees an increase in utilisation rates amid massive interest in weight-loss drugs, but it also faces a post-Covid reset

    • Weight-loss drugs have the potential to reach US$80 billion in sales by 2030, up from US$6 billion in 2023.
    • Weight-loss drugs have the potential to reach US$80 billion in sales by 2030, up from US$6 billion in 2023. PHOTO: AFP

    Chloe Nadia Halim

    Published Tue, Feb 20, 2024 · 07:03 PM

    FOR much of 2023, mega-cap technology stocks drove global equity market returns amid the excitement over artificial intelligence and its applications.

    Moreover, as the economy continued to defy expectations of a recession, defensive sectors were left behind. For instance, the healthcare sector delivered returns of 4.3 per cent in 2023, lagging behind most sectors and the broader equity market, measured by the MSCI World Index, which delivered returns of 24.5 per cent. 

    Top-performing healthcare segments

    The healthcare sector can be broadly broken down into five main segments: pharmaceuticals; healthcare equipment and supplies; healthcare provider and services; biotechnology; and life science tools and services.

    Investing Globally & ProfitablyHealthcare

    TRENDING NOW

    From shy teenager to outspoken philanthropist, Chloe Tong has come a long way.

    Grab CEO’s wife Chloe Tong on life with Anthony Tan and finding her purpose

    HDB said the listed price of S$2.18 million for the flat at 93B Telok Blangah Street 31 was “significantly higher” than comparable transactions in the area.

    HDB reviewing ‘jumbo’ flat scheme after Telok Blangah unit listed for sale at S$2.18m

    From left: Pham Nhat Quan Anh, Pham Nhat Vuong, Pham Thu Huong and Pham Nhat Minh Hoang. The couple (centre) remain senior figures in Vingroup, with their children’s presence in the ecosystem growing.

    He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons

    The judge also rejected Radiant World’s argument that a claim against Glencore for about US$2 billion should be regarded as a “realisable asset”.

    Singapore judge raises doubts iron ore trader Radiant World is owed US$1 billion

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More